These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 19595104

  • 1. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104
    [Abstract] [Full Text] [Related]

  • 2. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB, Wu F, Wang ZB, Chen WZ, Zhu H.
    Zhonghua Zhong Liu Za Zhi; 2003 Jul 24; 25(4):401-3. PubMed ID: 12921577
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.
    Li C, Zhang W, Zhang R, Zhang L, Wu P, Zhang F.
    Eur J Cancer; 2010 Sep 24; 46(13):2513-21. PubMed ID: 20663659
    [Abstract] [Full Text] [Related]

  • 4. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
    Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Jin CB, Xie FL, Su HB.
    Radiology; 2005 May 24; 235(2):659-67. PubMed ID: 15858105
    [Abstract] [Full Text] [Related]

  • 5. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS.
    Ai Zheng; 2005 Jul 24; 24(7):827-33. PubMed ID: 16004809
    [Abstract] [Full Text] [Related]

  • 6. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug 24; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

  • 7. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis.
    Jin C, Zhu H, Wang Z, Wu F, Chen W, Li K, Su H, Zhou K, Gong W.
    Eur J Radiol; 2011 Dec 24; 80(3):662-9. PubMed ID: 20864286
    [Abstract] [Full Text] [Related]

  • 8. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Gao HJ, Liang HH, Chen MS, Peng ZW, Zhang YJ, Li P, Pang XH, Zhang YQ, Li JQ.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2529-32. PubMed ID: 19080642
    [Abstract] [Full Text] [Related]

  • 9. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, Zhang YQ, Lau WY.
    Eur J Surg Oncol; 2010 Mar 23; 36(3):257-63. PubMed ID: 19643561
    [Abstract] [Full Text] [Related]

  • 10. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J, Wu Z, Tang Z.
    Zhonghua Wai Ke Za Zhi; 2001 Oct 23; 39(10):745-8. PubMed ID: 16201184
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y.
    Radiol Med; 2002 May 10; 104(5-6):412-20. PubMed ID: 12589262
    [Abstract] [Full Text] [Related]

  • 13. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H.
    Hepatogastroenterology; 2001 May 10; 48(41):1409-15. PubMed ID: 11677976
    [Abstract] [Full Text] [Related]

  • 14. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR, Kang Z, Qian JS, Zhu KS, Jiang ZB, Huang MS, Guan SH, Shan H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov 10; 27(11):1749-51. PubMed ID: 18024306
    [Abstract] [Full Text] [Related]

  • 15. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM, Wang JH, Zhen ZJ, Chen HW, Cui WZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov 10; 26(11):1626-8. PubMed ID: 17121718
    [Abstract] [Full Text] [Related]

  • 16. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma.
    Shim SJ, Seong J, Han KH, Chon CY, Suh CO, Lee JT.
    Liver Int; 2005 Dec 10; 25(6):1189-96. PubMed ID: 16343071
    [Abstract] [Full Text] [Related]

  • 17. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M, Wu PH, Zeng YX, Xia JC, Zhang FJ, Xian LJ, Zhang YP, Zhou K, Fan WJ, Zhang L, Gao F, Zhou QM.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1823-8. PubMed ID: 17054858
    [Abstract] [Full Text] [Related]

  • 18. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK.
    Ai Zheng; 2004 Jul 11; 23(7):829-32. PubMed ID: 15248922
    [Abstract] [Full Text] [Related]

  • 19. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH, Walser EM, Paz-Fumagalli R, McKinney JM, May GR.
    Cardiovasc Intervent Radiol; 2007 Jul 11; 30(5):888-93. PubMed ID: 17619218
    [Abstract] [Full Text] [Related]

  • 20. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec 11; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.